Renal Cell Carcinoma Fuhrman Grade and Histological Subtype Correlate With Complete Polymorphic Deletion of Glutathione S-Transferase M1 Gene

Journal of Urology

Volumn 183, Issue 3, 2010, Pages 878-883

  De Martino, Michela ^a   Klatte, Tobias ^a   Schatzl, Georg ^a   Remzi, Mesut ^a   Waldert, Matthias ^a   Haitel, Andrea ^a   Stancik, Igor ^b   Kramer, Gero ^a   Marberger, Michael ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b Hietzing Hospital   (Austria)

Author keywords

carcinoma; gene deletion; genetic; glutathione transferase; kidney; polymorphism; renal cell

Indexed keywords

GLUTATHIONE TRANSFERASE M1; GLUTATHIONE TRANSFERASE T1;

ADULT; AGAR GEL ELECTROPHORESIS; AGED; ARTICLE; CANCER GROWTH; CANCER SURVIVAL; CONTROLLED STUDY; DNA POLYMORPHISM; FEMALE; GENE DELETION; GENOTYPE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; KIDNEY CARCINOMA; MAJOR CLINICAL STUDY; MALE; MULTIPLEX POLYMERASE CHAIN REACTION; PRIORITY JOURNAL;

CARCINOMA, RENAL CELL; DISEASE PROGRESSION; FEMALE; GENE DELETION; GLUTATHIONE TRANSFERASE; HUMANS; KIDNEY NEOPLASMS; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC;

EID: 75849150533     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.juro.2009.11.032     Document Type: Article

References (30)

1. Klatte T., and Pantuck A.J. Molecular biology of renal cortical tumors. Urol Clin North Am 35 (2008) 573
2. Benichou J., Chow W.H., McLaughlin J.K., et al. Population attributable risk of renal cell cancer in Minnesota. Am J Epidemiol 148 (1998) 424
3. Buzio L., De P.G., Mozzoni P., et al. Glutathione S-transferases M1-1 and T1-1 as risk modifiers for renal cell cancer associated with occupational exposure to chemicals. Occup Environ Med 60 (2003) 789
4. Karami S., Boffetta P., Rothman N., et al. Renal cell carcinoma, occupational pesticide exposure and modification by glutathione S-transferase polymorphisms. Carcinogenesis 29 (2008) 1567
5. Sweeney C., Farrow D.C., Schwartz S.M., et al. Glutathione S-transferase M1, T1, and P1 polymorphisms as risk factors for renal cell carcinoma: a case-control study. Cancer Epidemiol Biomarkers Prev 9 (2000) 449
6. McIlwain C.C., Townsend D.M., and Tew K.D. Glutathione S-transferase polymorphisms: cancer incidence and therapy. Oncogene 25 (2006) 1639
7. Cho S.G., Lee Y.H., Park H.S., et al. Glutathione S-transferase mu modulates the stress-activated signals by suppressing apoptosis signal-regulating kinase 1. J Biol Chem 276 (2001) 12749
8. Smits K.M., Schouten L.J., van Dijk B.A., et al. Polymorphisms in genes related to activation or detoxification of carcinogens might interact with smoking to increase renal cancer risk: results from The Netherlands Cohort Study on diet and cancer. World J Urol 26 (2008) 103
9. Karagas M.R., Park S., Warren A., et al. Gender, smoking, glutathione-S-transferase variants and bladder cancer incidence: a population-based study. Cancer Lett 219 (2005) 63
10. Longuemaux S., Delomenie C., Gallou C., et al. Candidate genetic modifiers of individual susceptibility to renal cell carcinoma: a study of polymorphic human xenobiotic-metabolizing enzymes. Cancer Res 59 (1999) 2903
11. Rebbeck T.R. Molecular epidemiology of the human glutathione S-transferase genotypes GSTM1 and GSTT1 in cancer susceptibility. Cancer Epidemiol Biomarkers Prev 6 (1997) 733
12. Strange R.C., Lear J.T., and Fryer A.A. Glutathione S-transferase polymorphisms: influence on susceptibility to cancer. Chem Biol Interact, 111- 112 (1998) 351
13. Strange R.C., and Fryer A.A. The glutathione S-transferases: influence of polymorphism on cancer susceptibility. IARC Sci Publ (1999) 231
14. Howells R.E., Holland T., Dhar K.K., et al. Glutathione S-transferase GSTM1 and GSTT1 genotypes in ovarian cancer: association with p53 expression and survival. Int J Gynecol Cancer 11 (2001) 107
15. Howells R.E., Redman C.W., Dhar K.K., et al. Association of glutathione S-transferase GSTM1 and GSTT1 null genotypes with clinical outcome in epithelial ovarian cancer. Clin Cancer Res 4 (1998) 2439
16. Davies S.M., Robison L.L., Buckley J.D., et al. Glutathione S-transferase polymorphisms and outcome of chemotherapy in childhood acute myeloid leukemia. J Clin Oncol 19 (2001) 1279
17. Eble J.N., Togashi K., and Pisani P. Tumours of the kidney. In: Eble J.N., Sauter G., Epstein J.I., et al. (Eds). World Health Organization Classification of Tumours: Pathology and Genetics of Tumours of the Urinary System and Male Genital Organs (2004), IARC Press, Lyon 9-87 chapt 1
18. Kidney. AJCC Cancer Staging Manual. 6th ed. (2002), Springer, New York 323-325 American Joint Committee on Cancer
19. Fuhrman S.A., Lasky L.C., and Limas C. Prognostic significance of morphologic parameters in renal cell carcinoma. Am J Surg Pathol 6 (1982) 655
20. Rowe J.D., Nieves E., and Listowsky I. Subunit diversity and tissue distribution of human glutathione S-transferases: interpretations based on electrospray ionization-MS and peptide sequence-specific antisera. Biochem J 325 (1997) 481
21. Rodilla V., Benzie A.A., Veitch J.M., et al. Glutathione S-transferases in human renal cortex and neoplastic tissue: enzymatic activity, isoenzyme profile and immunohistochemical localization. Xenobiotica 28 (1998) 443
22. Bruning T., Lammert M., Kempkes M., et al. Influence of polymorphisms of GSTM1 and GSTT1 for risk of renal cell cancer in workers with long-term high occupational exposure to trichloroethene. Arch Toxicol 71 (1997) 596
23. Dorion S., Lambert H., and Landry J. Activation of the p38 signaling pathway by heat shock involves the dissociation of glutathione S-transferase Mu from Ask1. J Biol Chem 277 (2002) 30792
24. Ambrosone C.B., Sweeney C., Coles B.F., et al. Polymorphisms in glutathione S-transferases (GSTM1 and GSTT1) and survival after treatment for breast cancer. Cancer Res 61 (2001) 7130
25. Sweeney C., Nazar-Stewart V., Stapleton P.L., et al. Glutathione S-transferase M1, T1, and P1 polymorphisms and survival among lung cancer patients. Cancer Epidemiol Biomarkers Prev 12 (2003) 527
26. Chenevix-Trench G., Young J., Coggan M., et al. Glutathione S-transferase M1 and T1 polymorphisms: susceptibility to colon cancer and age of onset. Carcinogenesis 16 (1995) 1655
27. Nascimento H., Coy C.S., Teori M.T., et al. Possible influence of glutathione S-transferase GSTT1 null genotype on age of onset of sporadic colorectal adenocarcinoma. Dis Colon Rectum 46 (2003) 510
28. Taioli E., Gaspari L., Benhamou S., et al. Polymorphisms in CYP1A1, GSTM1, GSTT1 and lung cancer below the age of 45 years. Int J Epidemiol 32 (2003) 60
29. Jung E.J., Lee H.J., Kwak C., et al. Young age is independent prognostic factor for cancer-specific survival of low-stage clear cell renal cell carcinoma. Urology 73 (2009) 137
30. Scoll B.J., Wong Y.N., Egleston B.L., et al. Age, tumor size and relative survival of patients with localized renal cell carcinoma: a surveillance, epidemiology and end results analysis. J Urol 181 (2009) 506